tiprankstipranks
Trending News
More News >
Advertisement

SCHY - ETF AI Analysis

Compare

Top Page

SCHY

Schwab International Dividend Equity ETF (SCHY)

Rating:61Neutral
Price Target:
SCHY, the Schwab International Dividend Equity ETF, has a solid but not top-tier rating, reflecting a mix of strong dividend-focused blue chips and some valuation or momentum concerns. High-quality holdings like TotalEnergies, GlaxoSmithKline, and Roche support the fund’s rating through solid financial performance, attractive valuations, and positive business outlooks. However, several key positions such as Wesfarmers, Unilever, and British American Tobacco face issues like bearish technical trends, high valuations, or earnings volatility, and the fund’s concentration in international dividend stocks means investors should be mindful of sector and regional risks abroad.
Positive Factors
Strong Recent Performance
The ETF has shown steady gains over the past month and quarter, indicating positive recent momentum.
Low Expense Ratio
The fund charges a relatively low fee, which helps investors keep more of their returns over time.
Broad International Diversification
Holdings spread across many countries and sectors help reduce the impact of problems in any single market or industry.
Negative Factors
Concentrated Country Exposure
A large portion of the portfolio is invested in a few countries like the UK and Switzerland, which can increase risk if those markets struggle.
Mixed Performance Among Top Holdings
Several of the largest positions have been weak or lagging this year, which can drag on overall returns.
Limited Technology Exposure
The fund has only a small allocation to technology stocks, so investors may miss out if that sector continues to perform strongly.

SCHY vs. SPDR S&P 500 ETF (SPY)

SCHY Summary

SCHY is the Schwab International Dividend Equity ETF, which follows the Dow Jones International Dividend 100 Index. It invests in large and mid-sized companies outside the U.S. that pay relatively high dividends, giving investors income plus global diversification. The fund owns well-known names like BHP Group and Roche, along with many other companies across Europe, Asia, and Australia. Someone might consider SCHY if they want regular dividend income and to spread their investments beyond the U.S. A key risk is that international stock prices and currencies can go up and down, so your investment value and income can fluctuate.
How much will it cost me?The Schwab International Dividend Equity ETF (SCHY) has an expense ratio of 0.08%, which means you’ll pay $0.80 per year for every $1,000 invested. This is lower than average because SCHY is passively managed, tracking an index rather than relying on active stock picking.
What would affect this ETF?SCHY's focus on high dividend yields from international markets could benefit from stable economic growth in developed countries outside the U.S., as well as increased demand for defensive sectors like Consumer Defensive and Health Care during uncertain times. However, the ETF may face challenges from rising interest rates, which can make dividend-paying stocks less attractive, and potential regulatory changes or economic slowdowns in key regions where its top holdings operate. Geographic diversification helps mitigate some risks, but currency fluctuations and geopolitical tensions could also impact performance.

SCHY Top 10 Holdings

SCHY’s story is all about steady, dividend-rich stalwarts outside the U.S., with health care and consumer names setting the tone. Pharma heavyweights like GSK, ONO, and Roche are rising and doing much of the heavy lifting, while industrial player Vinci and energy giant TotalEnergies add a solid, cyclical backbone. Consumer staples such as Unilever are more mixed, occasionally losing steam but still supporting income. With big positions in Europe, Japan, and Australia and no single stock dominating, the fund feels diversified yet clearly tilted toward defensive, dividend-focused leaders.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
BHP Group Ltd4.85%$101.99MAU$263.86B47.44%
68
Neutral
TotalEnergies SE4.51%$94.72M€149.73B23.80%
78
Outperform
GlaxoSmithKline4.19%$88.14M£82.75B38.66%
77
Outperform
ONO Pharmaceutical Co4.05%$85.11M¥1.12T30.60%
75
Outperform
Vinci SA4.02%$84.46M€72.92B11.39%
76
Outperform
Roche Holding AG3.99%$83.91MCHF263.94B22.97%
73
Outperform
Enel S.p.A.3.93%$82.52M€96.04B35.71%
67
Neutral
ENI S.p.A.3.79%$79.64M€62.25B55.93%
63
Neutral
British American Tobacco3.74%$78.67M£94.69B37.57%
71
Outperform
Wesfarmers Limited3.72%$78.24MAU$86.07B20.32%
68
Neutral

SCHY Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
31.76
Negative
100DMA
30.29
Positive
200DMA
28.71
Positive
Market Momentum
MACD
-0.07
Positive
RSI
36.98
Neutral
STOCH
19.66
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SCHY, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 32.89, equal to the 50-day MA of 31.76, and equal to the 200-day MA of 28.71, indicating a neutral trend. The MACD of -0.07 indicates Positive momentum. The RSI at 36.98 is Neutral, neither overbought nor oversold. The STOCH value of 19.66 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SCHY.

SCHY Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$2.13B0.08%
61
Neutral
$8.71B0.15%
69
Neutral
$8.44B0.61%
71
Outperform
$499.84M0.45%
58
Neutral
$140.85M0.75%
62
Neutral
$15.02M0.39%
65
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SCHY
Schwab International Dividend Equity ETF
31.46
7.21
29.73%
FDVV
Fidelity High Dividend ETF
FVD
First Trust Value Line Dividend Index Fund
DWX
SPDR S&P International Dividend ETF
IDVZ
Opal International Dividend Income ETF
VDI
Virtus International Dividend ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement